Concepedia

Naoyuki Maeda

NM

23

Publications

937

Citations

16

H-Index

1985

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Rakuno Gakuen University

Daiichi Sankyo (Germany)

National Cancer Center Hospital East

Shibuya (Japan)

Naoyuki Maeda is an author at Daiichi-Sankyo (Japan) specializing in medicine, physiology, and pharmacology.

ORCID

Top concepts

Publications per year

1985–2022

23

Publications

23

A Novel HER3-Targeting Antibody–Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization

Yuuri Hashimoto, Kumiko Koyama, Yasuki Kamai et al. · Clinical Cancer Research · 2019 · 164 citations

U3-1402, a Novel HER3-Targeting Antibody–Drug Conjugate, for the Treatment of Colorectal Cancer

Shigehiro Koganemaru, Yasutoshi Kuboki, Yoshikatsu Koga et al. · Molecular Cancer Therapeutics · 2019 · 95 citations

An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC

Kimio Yonesaka, Naoki Takegawa, Satomi Watanabe et al. · Oncogene · 2018 · 89 citations

, , +9

U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation

Koji Haratani, Kimio Yonesaka, Shiki Takamura et al. · Journal of Clinical Investigation · 2019 · 78 citations · Full text

Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice

Yoshiharu Hiruma, Naoyuki Maeda, Akiko Okada et al. · Bone · 2012 · 75 citations

, , +9

Rows per page

1–5 of 23